Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis

  1. Pozo-Rosich, P.
  2. Poveda, J.L.
  3. Crespo, C.
  4. Martínez, M.
  5. Rodríguez, J.M.
  6. Irimia, P.
Revista:
Journal of Headache and Pain

ISSN: 1129-2377,  1129-2369

Ano de publicación: 2024

Volume: 25

Número: 1

Tipo: Artigo

DOI: 10.1186/S10194-024-01747-W GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus